机译:氮杂胞苷加速/弹性相治疗费城阴性髓系肿瘤。 临床结果与预后因子的鉴定
HematologyFabrizio Spaziani HospitalFrosinone Italy;
HematologySan Gerardo HospitalMonza Italy;
HematologyBelcolle HospitalViterbo Italy;
UOSD of HematologyASL Roma 1Rome Italy;
HematologySacred Hearth Catholic University of RomeMilan Italy;
HematologyUniversity Tor VergataRome Italy;
HematologySant'Eugenio HospitalRome Italy;
HematologyPolo Universitario PontinoLatina Italy;
HematologySan Giovanni HospitalRome Italy;
Department of HematologySanto Spirito HospitalPescara Italy;
HematologyFabrizio Spaziani HospitalFrosinone Italy;
HematologySan Gerardo HospitalMonza Italy;
Hematology Department of Translational and Precision Medicine Policlinico Umberto ISapienza;
HematologySacred Hearth Catholic University of RomeMilan Italy;
Hematology Department of Translational and Precision Medicine Policlinico Umberto ISapienza;
HematologyBelcolle HospitalViterbo Italy;
Hematology Department of Translational and Precision Medicine Policlinico Umberto ISapienza;
Hematology Department of Translational and Precision Medicine Policlinico Umberto ISapienza;
accelerated phase; azacytidine; blastic phase; myeloproliferative neoplasms;
机译:氮杂胞苷加速/弹性相治疗费城阴性髓系肿瘤。 临床结果与预后因子的鉴定
机译:如何治疗费城染色体阴性髓原肿瘤的爆炸阶段
机译:诊断年龄是费城阴性髓原肿瘤的重要预后因素
机译:心理障碍,临床和生物学参数与费城阴性慢性肌酚瘤肿瘤患者的相关性研究
机译:骨髓增生性肿瘤中的新因素-NFIB和miRNA解除调节在造血细胞增殖和分化中的作用
机译:临床试验和观察:原始BCR-ABL-骨髓增生性肿瘤的自然病史和治疗结果
机译:如何对待费城染色体阴性髓鳞状肿瘤的爆炸阶段